Cagrilintide 10mg

Description

Cagrilintide 10mg For Sale — Amylin Analogue Research Peptide

Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk. Amylin is a pancreatic peptide co-secreted with insulin that plays a key role in postprandial glucose regulation, gastric emptying inhibition, and satiety signaling. Cagrilintide’s extended half-life (approximately 7 days) makes it a practical tool for chronic dosing research protocols.

Research Profile

Cagrilintide is being studied as a combination therapy partner — most notably with semaglutide in the CagriSema combination — with Phase 3 data showing additive weight reduction effects beyond either compound alone. Researchers studying amylin receptor biology, combination incretin approaches, and metabolic syndrome models have cited cagrilintide as a key contemporary research compound. The 10mg vial format supports extended research protocols.

Product Specifications

• Compound: Cagrilintide (long-acting amylin analogue)
• Amount: 10mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Testing: Third-party Certificate of Analysis available
• Storage: -20°C lyophilized; 4°C after reconstitution, use within 28 days
• For laboratory and research use only — not for human consumption

For research and laboratory use only. Not intended for human consumption.